When Will GenAI Finally Deliver Returns On Investment?

When Will GenAI Finally Deliver Returns On Investment?

Seattle-based start-up Pay-i says its new tools could help enterprises evaluate which GenAI projects will deliver meaningful value

Capgemini exec recommends reframing ROI metrics for pharma’s GenAI efforts

Pharma executives, observing peers in retail and banking tout GenAI payoffs “in weeks and months,” increasingly ask why their own firms can’t match that pace. This pressure for a ROI for an industry that has seen productivity gradually stall since the 1950s. So, when pharma executives ask Sheetal Chawla, Capgemini’s head of life sciences: “When… The post Capgemini’s life-sciences lead says ROI and data security, not algorithms, will decide pharm…

GenAI and the Future of DAM: A Balanced Evolution

This article contributed by Frank DeCarlo is part of our editorial series entitled ‘Will Generative AI Make DAM Obsolete?’   As generative AI technologies continue their meteoric rise—capable of creating images, video, text, and audio in real time—they are rewriting the rules of digital content. This rapid evolution is forcing …GenAI and the Future of DAM: A Balanced Evolution is a post from: Digital Asset Management News

GenAI Reshapes IT Services Talent Strategy as Vendors Balance...

GenAI training becomes table stakes for IT services and consulting, but specialization remains selective In the short-to-mid-term, TBR expects generative AI (GenAI)-specific training to become a standard part of an IT services or consulting professional’s basic tool kit, with specialized training around technology partners’ solutions or a company’s own IP and platforms reserved for those professionals dedicated to AI roles. While some may argue …